Lung squamous cell carcinoma metastasizing to the nasopharynx following bronchoscopy intervention therapies: a case report by Jian-bin Hu et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Hu et al. World Journal of Surgical Oncology 2014, 12:68
http://www.wjso.com/content/12/1/68CASE REPORT Open AccessLung squamous cell carcinoma metastasizing
to the nasopharynx following bronchoscopy
intervention therapies: a case report
Jian-bin Hu1, Mei Jin2, En-guo Chen3 and Xiao-nan Sun1*Abstract
Metastatic carcinoma to the nasopharynx is extremely rare, and few cases have been reported in the literature. In
the present report, we describe the case of a patient with a mass in the nasopharynx found by bronchoscopy. Our
patient was a 61-year-old man receiving multiple bronchoscopy intervention therapies for advanced lung squamous
cell carcinoma (SCC), which was histopathologically confirmed. The SCC metastasized to the nasopharynx following
the bronchoscopy intervention therapies. The lesion was considered metastatic from lung cancer on the basis of
clinical and histological clues. The exact mechanism of lung cancer metastasis to the nasopharynx in this case
remains unclear because either implantation or hematogenous and lymphatic spread is possible. A thorough head
and neck examination should be undertaken during bronchoscopic evaluation, especially in patients receiving
bronchoscopy intervention therapies. The early detection of a silent nasopharyngeal metastasis is important to
choosing from among the multiple treatment options available.
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Carcinoma metastatic to the nasopharynx is rare, and
there are few reports in the literature concerning this
condition [1,2]. More specifically, nasopharyngeal metas-
tasis from lung cancer is extremely rare, with very few
cases reported to date [3,4]. In this case report, we de-
scribe an unusual case of lung squamous cell carcinoma
(SCC) that metastasized to the nasopharynx following
bronchoscopy intervention therapies.
Case presentation
A 61-year-old man who was a heavy cigarette smoker-
presented to our department with a mass in the naso-
pharynx found by bronchoscopy. He had been diagnosed
with SCC of the left lower lung by bronchoscopic biopsy
2 years earlier. He was staged with T4N0M0 disease
after systemic evaluation at that time. Thereafter he re-
ceived a presumed curative left pneumonectomy, which* Correspondence: sunxiaonan@hotmail.com
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unless otherwise stated.revealed moderately differentiated SCC with no lymph
node metastases and a clear bronchial resection margin.
He was given four cycles of adjuvant chemotherapy with
regular doses of gemcitabine and cisplatin. His disease
had remained stable for 1 year until 6 months before his
presentation to our hospital.We founda recurrent mass
in the end of his trachea by chest computed tomography
and bronchoscopy (Figure 1), and, on the basis of a
bronchoscopic biopsy, we confirmed the mass to be a
well- to moderately differentiated SCC. To alleviate the
patient’s symptoms of respiratory obstruction, tumor re-
moval was carried out through bronchoscopy interven-
tion therapies, including argon knife, electric snare,
cryotherapy and hot biopsy forceps. His symptoms were
relieved after these procedures. However, his symptoms
recurred 1.5 months later. A similar mass was found
again in the end of the trachea, with the same patho-
logical result confirmed by biopsy. The second-course
tumor removal through bronchoscopy intervention ther-
apy was carried out, followed by one course of con-
formal external beam radiation to the tumor bed at a
dose of 6,600 cGy in 33 fractions. Three months after
the completion of radiotherapy, a cauliflower-like massThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Scans of the patient’s chest show the mass in the end
of the trachea. (A) Computed tomography scan. (B) Bronchoscopy.
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ing a routine follow-up bronchoscopic evaluation. Biopsy
of the nasopharyngeal mass confirmed it to be SCC.
The patient was referred to our department for further
evaluation. Serum tests of antibodies to Epstein-Barr virus
(EBV) were negative. Magnetic resonance imaging revealed
a solitary mass in the torus tubarius of the nasopharynx
without paranasopharyngeal space involvement (Figure 2).
Owing to the patient’s advanced disease and poor general
condition, palliative removal of the lesion in the nasophar-
ynx was carried out through bronchoscopy intervention
therapy. Histopathological examinationof hematoxylin and
eosin–stained sections of the nasopharyngeal lesion re-
vealed typical SCC composed of large, eosinophilic cells
with distinct cell borders, keratinization and the forma-
tion of small horn pearls. The histopathological morph-
ology of the nasopharyngeal lesion was similar to that of
the primary tumor of the trachea (Figure 3). To identify
the origin of the lesions, samples of nasopharyngeal andtracheal masses were analyzed for EBV infection status
by the technique of EBV-encoded RNA in situ hybrid-
ization (EBER-ISH). EBER-ISH tests of both lesionswere
negative. The patient received an additional five cycles of
chemotherapy with regular doses of taxotere and cis-
platin. He remained disease-free at his 6-month follow-
up examination.
Discussion
As defined by the World Health Organization classifi-
cation system, nasopharyngeal carcinoma (NPC) histo-
pathologically can be classified into undifferentiated
carcinoma (UC), differentiated nonkeratinizing carcinoma
(NKC) and SCC [5]. In the case of our patient, examin-
ation of tissues obtained from of the nasopharynx was
enough to establish the diagnosis of SCC. Histologically,
the tumor shows prominent features of keratinization, in-
cluding the presence of squamous pearl formation and
evident intercellular bridges. Negative serum antibody to
EBV and negative EBER-ISH, which is almost invariably
positive in UC and NKC and less often positive in SCC,
also support the diagnosis [6-8]. However, identification of
metastatic or primary nature of nasopharyngeal SCC is
difficult and is imperative in making the appropriate prog-
nostic evaluation and choosing the best treatment option.
In our patient, a documented previous history of advanced
lung SCC associated with recurrence was highly suggestive
of the metastatic nature of the lesion in the nasopharynx.
However, tumors seldom metastasize to the nasopharynx.
In contrast, the incidence of primary lung cancer associ-
ated with second primary tumors in the head and neck
area is 1% to 2% [9,10]. Because of the very low prevalence
of nasopharyngeal metastasis and relatively more common
secondary primary tumors, it could be argued that a
history of malignancy does not necessarily imply that a
nasopharyngeal lesion is metastatic in nature. It is indeed
well-known among pathologists that there are currently
no immunohistochemical markers for the determination
of the likely site of origin of SCC, even though this is pos-
sible for adenocarcinomas in most cases [11]. Some rele-
vant and heuristic studies have been carried out in recent
years. Kanthan et al. adopted cytokeratin CK5, p63 and
p16 as immunohistochemical markers to confirm the
diagnosis of SCC of the cervix metastatic to the duode-
num [12]. Huang et al. performed immunohistochemical
staining to compare the expression pattern of the epithe-
lial–mesenchymal transition markers between primary
SCC of the hypopharynx and a metastatic lesion of the
duodenum [13]. Zhang et al. identified the SPLUNC1and
LPLUNC1 genes by suppression subtractive hybridization
and cDNA microarray. These genes are specifically ex-
pressed in normal adult nasopharyngeal epithelial tissue
and trachea and downexpressed in NPC [14]. Gevaert
et al. studied the expression profiles of a series of human
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Figure 2 Scans show the mass in the torus tubarius of the nasopharynx. (A) Magnetic resonance imaging scan. (B) Bronchoscopy.
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technology. Strikingly, they concluded that SCCs do not
reflect their primary tissue expression profile because of
the absence of a molecular signature in these tumors that
reflects their tissue of origin [15]. Therefore, the differen-
tiation between primary and metastasis of nasopharyngeal
SCC currently depends mainly on clinical and histological
signs. In our region, malignancies in the nasopharynx are
largely confined to the pharyngeal recess [16]. Some have
argued that the roof of the nasopharyngeal cavity may be
the area most likely to develop the original carcinomat-
ous microfocus, followed in frequency by the posterior
wall [17]. Early cancers localized to the torus tubarius are
rarely reported. Histologically, undifferentiated or NKC is
the main subtype, which is associated with the EBV gen-
ome within the tumor and intratumoral lymphoid infil-
trate. Keratinizing SCC is uncommon and accounts for
only about 5% of cases [18]. The clinical clues highly
reminiscent of metastasis to the nasopharynx in thiscase include a documented previous history of advanced
lung SCC associated with recurrence, the uncommon lo-
cation of the lesion, the cauliflower-like tumor growth
without paranasopharyngeal space involvement, the ab-
sence of enlarged cervical lymph nodes, negative serum
antibody to EBV and multiple bronchoscopy interven-
tion therapies. Histological signs suggestive of metasta-
sis include the unusual histological subtype, negative
EBER-ISH, lack of local inflammatory response and ab-
sence of squamous metaplasia in the mucosa adjacent to
the tumor.
The exact mechanism of lung cancer metastatic to the
nasopharynx in our patient remains unclear. Significantly,
during his treatment, the patient underwent two-course
bronchoscopy intervention therapies for obstruction of
the airway through his right nostril. Portsite metastasis
secondary to instrumentation in laparoscopic surgery has
been well-documented. Numerous mechanisms have been
proposed, including implantation, leakage of insufflation
AB
Figure 3 Histopathological specimen images. Nasopharynx
specimen (A) showing squamous cell carcinoma with morphology
similar to that of the primary lesion of the trachea (B).
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of pneumoperitoneum on local immune reactions [19].
More than 30 cases of metastatic spread to a percutaneous
endoscopic gastrostomy site in patients with head and
neck cancer have been reported [20], and direct implant-
ation of cells is considered more likely than hematogenous
spread [21]. More rarely, cases of nasal tip metastasis from
various malignancies have been reported as well [22]. It
can be postulated that the metastatic mechanism is similar
with the use of such instrumentation. Implantation is the
most likely cause. It has been shown that instruments har-
bor tumor cells and that tissue trauma, tumor manipula-
tion and spillage increase the chances of tumor seeding
[23]. Hematogenous and lymphatic spread must also be
considered. It is well-known that metastases often favor
sites of trauma. It is possible, therefore, that the nasopha-
ryngeal mucosa traumatized by the bronchoscopy in our
patient may have attracted blood-borne metastases. This
hypothesis is in agreement with our patient’s advancedcancer stage, which implies that tumor cells were circulat-
ing in the lymphatic channels and bloodstream.
Because of the extreme rarity of nasopharyngeal me-
tastasis, there is no consensus regarding the best treat-
ment. Wong et al. reported the case of a patient with
adenocarcinoma of the lung with solitary nasopharyngeal
metastasis. Their patient received palliation radiotherapy
and remained disease-free for 10 years from the date of
diagnosis of nasopharyngeal metastasis, and they postu-
lated that solitary nasopharyngeal metastasis from lung
primary tumor might be a separate entity that responds
well to radiotherapy [4]. Saab et al. reported the case of
a patient with breast carcinoma metastatic to the naso-
pharynx with a dismal result due to delay of treatment
[1]. In our present case, we adopted palliative bronchos-
copy intervention therapy but not radiotherapy to the
nasopharyngeal lesion because of the metastatic nature
with implantation as the probable cause, the absence
of an enlarged cervical lymph node or paranasophar-
yngeal space involvement and the advanced primary
lung cancer. The long-term result of treatment awaits fur-
ther evaluation.
Conclusions
Metastasis to the nasopharynx from primary lung cancer
is a rare occurrence. A thorough head and neck exam-
ination should be undertaken during bronchoscopic
evaluation, especially in patients receiving bronchos-
copy intervention therapies. The early detection of a si-
lent nasopharyngeal metastasis is meaningful in choosing
from among the multiple treatment options available.
Otherwise, such a metastasis could become symptomatic
and difficult to control because of its potential to invade
the base of the skull.
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